id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-D-1542-0005,FDA,FDA-2000-D-1542,"Attachment I - Sample Formats—Application To Manufacture - Ammonia N 13 Injection Fludeoxyglucose F 18 Injection (FDG F 18) and Sodium Fluoride F 18 Injection Chemistry, Manufacturing, and Controls Section [FDA-2000-D-1542-0002]",Supporting & Related Material,GDL-Guidance,2009-11-16T05:00:00Z,2009,11,,,2009-11-16T20:09:17Z,,0,0,0900006480a5891e
FDA-2000-D-1542-0001,FDA,FDA-2000-D-1542,Draft Guidance for Industry on the Content and Format of New Drug Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug Products; Availability,Notice,NAD-Notice of Availability of Data,2009-11-16T05:00:00Z,2009,11,2009-11-16T05:00:00Z,2000-06-09T03:59:59Z,2009-11-16T19:37:14Z,,0,0,09000064804f9074